The intestine as a possible target for fumonisin toxicity.
about
Food chain mycotoxin exposure, gut health, and impaired growth: a conceptual frameworkEnvironment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesisThe intestinal barrier as an emerging target in the toxicological assessment of mycotoxinsFumonisins affect the intestinal microbial homeostasis in broiler chickens, predisposing to necrotic enteritisPrevalence and effects of mycotoxins on poultry health and performance, and recent development in mycotoxin counteracting strategiesMouldy feed, mycotoxins and Shiga toxin - producing Escherichia coli colonization associated with Jejunal Hemorrhage Syndrome in beef cattleA prebiotic, Celmanax™, decreases Escherichia coli O157:H7 colonization of bovine cells and feed-associated cytotoxicity in vitro.Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisinToxic mechanisms induced by fumonisin b1 mycotoxin on human intestinal cell line.Chronic exposure to deoxynivalenol has no influence on the oral bioavailability of fumonisin B1 in broiler chickensPattern recognition receptors in the gut: analysis of their expression along the intestinal tract and the crypt/villus axis.Dose-dependent effects on sphingoid bases and cytokines in chickens fed diets prepared with fusarium verticillioides culture material containing fumonisinsGrowth performance, serum biochemical profile, jejunal morphology, and the expression of nutrients transporter genes in deoxynivalenol (DON)- challenged growing pigsThe Potential Role of Mycotoxins as a Contributor to Stunting in the SHINE Trial.Gastrointestinal Degradation of Fumonisin B₁ by Carboxylesterase FumD Prevents Fumonisin Induced Alteration of Sphingolipid Metabolism in Turkey and SwineModulation of intestinal functions following mycotoxin ingestion: meta-analysis of published experiments in animals.Effect of low dose of fumonisins on pig health: immune status, intestinal microbiota and sensitivity to SalmonellaThe food contaminant fumonisin B(1) reduces the maturation of porcine CD11R1(+) intestinal antigen presenting cells and antigen-specific immune responses, leading to a prolonged intestinal ETEC infectionAflatoxin, fumonisin and Shiga toxin-producing Escherichia coli infections in calves and the effectiveness of Celmanax®/Dairyman's Choice™ applications to eliminate morbidity and mortality losses.Effect of Fusarium-Derived Metabolites on the Barrier Integrity of Differentiated Intestinal Porcine Epithelial Cells (IPEC-J2).The role of biomarkers in evaluating human health concerns from fungal contaminants in food.From the gut to the brain: journey and pathophysiological effects of the food-associated trichothecene mycotoxin deoxynivalenol.Impact of mycotoxins on the intestine: are mucus and microbiota new targets?Deoxynivanelol and fumonisin, alone or in combination, induce changes on intestinal junction complexes and in E-cadherin expression.Strategies to reduce exposure of fumonisins from complementary foods in rural Tanzania.A proposed method to determine fumonisin exposure from maize consumption in a rural South African population using a culturally appropriate FFQ.New insights into the organ-specific adverse effects of fumonisin B1: comparison between lung and liver.Hydrolysed fumonisin B1 and N-(deoxy-D-fructos-1-yl)-fumonisin B1: stability and catabolic fate under simulated human gastrointestinal conditions.Impact of two mycotoxins deoxynivalenol and fumonisin on pig intestinal health.The potential effects of antioxidant feed additives in mitigating the adverse effects of corn naturally contaminated with Fusarium mycotoxins on antioxidant systems in the intestinal mucosa, plasma, and liver in weaned pigs.Oral and Intravenous Fumonisin Exposure in Pigs-A Single-Dose Treatment Experiment Evaluating Toxicokinetics and Detoxification.
P2860
Q27003457-E21E3F7A-4544-4640-9B5B-9C80A5D50FB5Q27024805-A78E4915-A356-4260-9513-A89CB4C69E9BQ28277155-032BBB12-4D98-41D2-BBE1-03D06152490FQ28607348-8B10DBF0-ACED-4EF6-86ED-A2B3CA044F80Q28829928-E31833ED-C2F4-4A0D-B907-5F9E4DDF8C84Q31015685-35FC5789-6833-414B-BBE6-8DE42AF5DA56Q33865231-BC8F199C-F874-4A1B-8E3B-D67F4787B973Q34652372-E9BA6F3D-8C72-4967-A869-E210F3BC836BQ35096940-33F4471B-C551-4F55-84F5-C08D6AC74CEDQ35131570-A88732EA-1979-4E09-B9E5-6B83E5131861Q35363430-EFA3A51F-971A-4E4C-BF00-A37512CB6FBAQ35564054-E86DC184-D7F2-47F7-B828-3B3AE40E2357Q35681711-25331432-1994-41C6-ABEC-56B6A1018E60Q36311606-8FC94187-A5FE-461D-986A-27C26775D1B7Q36735609-D3EC6C3C-BBBB-4667-9865-6C76079A5DDAQ36807203-D1A60DD2-128E-404B-A3EB-C008D243E200Q36993931-5A67F7F9-52D2-4CBD-8FCF-15F7B4591BA6Q37239411-1B81C49F-FC54-4EBB-BA2E-33D502485CC0Q37269935-F374C9EB-4DB3-4866-9340-FF338A916D99Q37450471-AF021D1B-5F05-42EF-B63E-7B7DA8218E8EQ38014991-36854F86-5881-4C5F-BFE6-96EC7B5F4B02Q38101247-B97978E7-60F7-409C-AD68-55172D4C881BQ39388126-1F4F09A6-2AD4-4B89-A4AE-4C13E719BFB8Q42774241-CB13C56C-CF25-41B6-A455-59AA496B4D99Q43939741-DDC4630B-F792-4B26-A1E9-5E4FE66B38CFQ45819429-E92D679B-31F5-459B-B5B3-091D9732648AQ46847888-445915E9-8BD1-44AC-9AEA-22D129BABC2EQ52996452-B5B32118-3892-4591-9AD8-D18362046C15Q53359672-999C2B26-E461-485A-92FB-9DBE9AB20CC1Q54306347-311FB877-3391-466C-A826-93B36EE4E0DAQ55270460-A23C7623-7B8B-42DF-BFEC-235FB2C40E5F
P2860
The intestine as a possible target for fumonisin toxicity.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The intestine as a possible target for fumonisin toxicity.
@en
type
label
The intestine as a possible target for fumonisin toxicity.
@en
prefLabel
The intestine as a possible target for fumonisin toxicity.
@en
P356
P1476
The intestine as a possible target for fumonisin toxicity
@en
P2093
Sandrine Bouhet
P2860
P304
P356
10.1002/MNFR.200600266
P577
2007-08-01T00:00:00Z